Concomitant therapy with direct-acting antivirals and chemoimmunotherapy in HCV-associated diffuse large B-cell lymphoma

Vincenzo Occhipinti(University of Milan), Maria Grazia Rumi(University of Milan), Lucia Farina(Fondazione IRCCS Istituto Nazionale dei Tumori), Mauro Viganò(Ospedale San Giuseppe), Marco Capecchi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Sara Labanca(University of Milan), Paolo Corradini(Gruppo di Ricerca Geriatrica), Ilaria Fanetti(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Digestive and Liver Disease
November 3, 2018
10.1016/j.dld.2018.10.019
Cited by 18

Related Papers

Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2022|718
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis
|Gut|2009|406
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|405
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394